Literature DB >> 16838334

Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes.

Giovannella Palmieri1, Carmine Selleri, Liliana Montella, Goffredo Bulgarelli, Laura Vitiello, Ghassan Merkabaoui, Patrizia Ricci, Luigi Del Vecchio, Annamaria Masci, Luigi Racioppi, Bruno Rotoli.   

Abstract

Seven years after a surgically resected thymoma, a female patient affected by myasthenia gravis and Good's syndrome presented with paroxysmal nocturnal hemoglobinuria (PNH). Co-culture experiments and spectratyping analyses indicated that CD8+ lymphocytes were involved in damaging hematopoietic precursors. While PNH clones have been identified in various hematological disorders, the sequential association of thymoma and PNH has been unreported so far.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838334     DOI: 10.1002/ajh.20699

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

Authors:  Theodoros Kelesidis; Otto Yang
Journal:  Clin Immunol       Date:  2010-02-10       Impact factor: 3.969

2.  Myasthenia gravis and paroxysmal nocturnal hemoglobinuria after thymectomy: A rare association.

Authors:  Jean Galtier; Fanny Duval; Irène Machelart; Carine Greib; Estibaliz Lazaro; Jean-Luc Pellegrin; Jean-François Viallard; Regis Peffault de la Tour; Etienne Rivière
Journal:  EJHaem       Date:  2021-09-29

3.  Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia.

Authors:  Yazan Migdady; Adam J Olszewski
Journal:  Clin Med Insights Oncol       Date:  2011-11-03

4.  Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).

Authors:  M Zaman; A Huissoon; M Buckland; S Patel; H Alachkar; J D Edgar; M Thomas; G Arumugakani; H Baxendale; S Burns; A P Williams; S Jolles; R Herriot; R B Sargur; P D Arkwright
Journal:  Clin Exp Immunol       Date:  2018-10-21       Impact factor: 4.330

Review 5.  The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Authors:  Liliana Montella; Margaret Ottaviano; Rocco Morra; Erica Pietroluongo; Pietro De Placido; Marianna Tortora; Chiara Sorrentino; Gaetano Facchini; Sabino De Placido; Mario Giuliano; Giovannella Palmieri
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.